VEGFA and preeclampsia: To evaluate the in vivo pathophysiological consequences of AT1-AAs to the retina, we introduced AT1-AA purified from severe preeclampsia into pregnant rats on day 13 of gestation to determine the effect of AT1-AA on hypertensive retinopathy and level of TNF-α and VEGF in vitreous humor.